Liquidation Sale Polysciences Inc. Poly(trimethylene Carbonate-co-d,l-lactide), 50:50, Iv 0.9 Dl/g - Today Only [Xg2lLMZY]

Liquidation Sale Polysciences Inc. Poly(trimethylene Carbonate-co-d,l-lactide), 50:50, Iv 0.9 Dl/g - Today Only [Xg2lLMZY]

Polysciences Inc.'s Poly(Trimethylene Carbonate-Co-D,L-Lactide) is a cutting-edge biodegradable copolymer designed for a wide range of biomedical applications. This versatile material, known for its unique combination of properties, offers improved rigidity and increased biodegradability. Its 50:50 composition ensures a balanced blend of the monomers, making it ideal for various applications where flexibility and degradation control are crucial.

Product Specifications and Technical Details

This polymer boasts a viscosity of approximately 0.9 dL/g, which is indicative of its flow characteristics during processing. It appears as a light yellow to tan solid, offering easy identification. With a molecular weight that is not specified, it provides flexibility in processing and application. The biodegradation time for PTMCLLA ranges from weeks to months, allowing for controlled degradation in specific applications. The following are some key benefits and properties:

• High biodegradability
• Improved rigidity
• Controlled degradation time
• Viscosity: ~0.9 dL/g
• Appearance: Light yellow to tan solid

Applications and Benefits

The PTMCLLA copolymer is highly sought after in the biomedical field for its applications in drug delivery, tissue engineering, and wound healing. Its biodegradable nature and enhanced properties make it a suitable choice for developing advanced polymer systems. The product's versatility is further enhanced by its compatibility with various processing techniques, ensuring ease of use for researchers and developers. By choosing PTMCLLA, you are investing in a material that not only meets your technical requirements but also contributes to innovative solutions in the biomedical industry. Target audiences include researchers, pharmaceutical companies, and medical device manufacturers looking to advance their product lines.